as on
| Source : NSE
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
0.81%
Downside
1.24%
Upside
52 Week's Low
52 Week's High
15.63%
Downside
144.95%
Upside
Market Stats | |
Previous Close | ₹481.80 |
Open | ₹481.80 |
Volume | 1.17L |
Upper Circuit | ₹529.95 |
Lower Circuit | ₹433.65 |
Day's Low | ₹476.15 |
Day's High | ₹486 |
52 Week Low | ₹405 |
52 Week High | ₹1,175.9 |
Returns % | |
1 Month Return | -10.4 % |
3 Month Return | -14.56 % |
1 Year Return | -49.83 % |
3 Year Return | -39.49 % |
5 Year Return | -39.49 % |
Check Akums Drugs & Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹7,583.24 Cr
Return on Equity (ROE)
13.15
PE Ratio (TTM)
21.49
Return on capital employed (ROCE)
10.7
Industry PE ratio
43.37
Beta (LTM)
1.32
P/B Ratio
3.15
Dividend Yield
0PEG Ratio
3.79
Quarterly Earnings Growth YOY
5.69
EPS (TTM)
22.45
Sector
Pharmaceuticals
Book Value
199.01
Technical Analysis
Bearish
View Technical Analysis
Track how Akums Drugs & Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Akums Drugs & Pharmaceuticals Ltd in the last 5 years
Lowest (18.75x)
April 7, 2025
Today (21.49x)
August 21, 2025
Industry (43.37x)
August 21, 2025
Highest (66.86x)
August 19, 2024
Today’s Price to Earnings Ratio: 21.49x
Get updated buy, sell, and hold recommendations by analysts on Akums Drugs & Pharmaceuticals Ltd.
based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Akums Drugs & Pharmaceuticals Ltd. Average target price of ₹691.67
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Akums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd price forecast by 3 analysts
Upside of43.56%
High
₹720
Target
₹691.67
Low
₹655
Akums Drugs & Pharmaceuticals Ltd target price ₹691.67, a slight upside of 43.56% compared to current price of ₹480.05. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Akums Drugs & Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:20.29%
Forecast
Actual
Including amortisation and stock based compensations
Akums Drugs & Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:13.67%
Forecast
Actual
Source: S&P Global Market Intelligence
Get the annual and quarterly financial summary of Akums Drugs & Pharmaceuticals Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Akums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd’s net profit jumped 5.5% since last year same period to ₹63.48Cr in the Q1 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -57% fall in its net profits since last 3-months.
Read More about Earnings ResultsCheck stock indices that include Akums Drugs & Pharmaceuticals Ltd.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Akums Drugs & Pharmaceuticals Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 75.26% | 0.00 | |
Foreign Institutions | 4.24% | ||
Mutual Funds | 6.73% | 10.14 | |
Retail Investors | 8.93% | 0.87 | |
Others | 4.85% | 20.81 |
Compare market cap, revenue, PE, and other key metrics of Akums Drugs & Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
BUY | 7,583.24 | -7.9% | 0.53 | 343 | 4,118 | |
NA | 219.61 | 409.45% | 0.56 | -12 | 15 | |
NA | 137.71 | -11.79% | 0.00 | 12 | 69 | |
NA | 8.28 | 8.75% | 0.76 | NA | 27 | |
NA | 264.04 | 0.76% | 0.00 | 9 | 162 |
Latest news and events in one place to help you make informed investing decisions in Akums Drugs & Pharmaceuticals Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 6.11% to 6.73% in Jun 2025 quarter
Retail Holding Up
Retail Investor have increased holdings from 8.85% to 8.93% in Jun 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 75.26% of holdings in Jun 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 5.77% to 4.24% in Jun 2025 quarter
Price Dip
In the last 1 year, AKUMS stock has moved down by -49.8%
Organisation | Akums Drugs & Pharmaceuticals Ltd |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Akums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd share price today stands at ₹480.05, Open: ₹481.8, Previous Close: ₹481.8, High: ₹486, Low: ₹476.15, 52 Week High: ₹1175.9, 52 Week Low: ₹405 as on .
To buy Akums Drugs & Pharmaceuticals Ltd shares, you need to follow these steps:
Today's traded volume of Akums Drugs & Pharmaceuticals Ltd is 1.17L. Which means that 1.17L shares of Akums Drugs & Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Akums Drugs & Pharmaceuticals Ltd is ₹7,583.24 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Akums Drugs & Pharmaceuticals Ltd’s 52 week high is ₹1175.9 and 52 week low is ₹405. The current share price of Akums Drugs & Pharmaceuticals Ltd is ₹480.05, which is -59.18% down from its 52 week high and 18.53% up from its 52 week low.